United States · FDA National Drug Code directory
Siliq
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0187-0004_5fbd9beb-42b9-4360-8363-71f8f0c5a52e
- Product NDC
- 0187-0004
- Form
- INJECTION
- Composition / generic term
- Brodalumab
- Labeler
- Bausch Health US LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20170215
- Source listing expiry
- 20271231
Source-listed ingredients
- BRODALUMAB — 210 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE in 1 CARTON (0187-0004-02) / 1 INJECTION in 1 SYRINGE (0187-0004-00) · 0187-0004-02
- 2 INJECTION in 1 CARTON (0187-0004-03) · 0187-0004-03
- 1 INJECTION in 1 SYRINGE (0187-0004-04) · 0187-0004-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →